Drug Shortage Report for SANDOZ BRIMONIDINE

Last updated on 2024-07-03

Report ID 230185
Drug Identification Number 02305429
Brand name SANDOZ BRIMONIDINE
Common or Proper name BRIMONIDINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.2%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10ML
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-12
Estimated end date 2024-06-28
Actual end date 2024-07-02
Shortage status Resolved
Updated date 2024-07-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-07-03 English Compare
v6 2024-07-02 French Compare
v5 2024-07-02 English Compare
v4 2024-06-13 English Compare
v3 2024-06-12 French Compare
v2 2024-06-12 English Compare
v1 2024-06-12 English Compare

Showing 1 to 7 of 7